Solos Endoscopy announces new polymer dilator for MammoView Breast Endoscopy System

Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce the Company has designed and is set to develop a new polymer dilator for the MammoView™ Breast Endoscopy System. The MammoView™ System currently offers a dilator set with a metal housing. The newly redesigned dilator utilizes a polymer housing, which is significantly softer while still offering comparable durability to the metal dilator. The new polymer dilator will be offered in addition to the more commonly used metal dilator. The two versions of the dilator offer physicians options based on individual patient's requirements.

Solos Endoscopy has evaluated several firms for the development of the new polymer dilator and is close to making its selection. Solos recently announced that the Company is in the process of creating a quality management system that meets the requirements of the ISO 13485 standard, which is a major step in obtaining the CE Mark and the permission to sell medical devices in the European Union and Canada. As a result of this announcement, candidates for the production of the new polymer dilator had to meet strict qualifications. In addition to their compliance with the FDA's Quality System Regulation, the candidates are also required to be ISO 13485 registered and create a CE Technical File for the new dilator.

"The new polymer dilator will be a valuable addition to our MammoView system," stated Bob Segersten, President of Solos Endoscopy, Inc. "The market for our product has been calling for a dilator that offers less discomfort to patients. We are pleased that Solos can soon offer this alternative."

SOURCE Solos Endoscopy, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New guidance balances GLP-1 risks and benefits for surgery